老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Propanc Biopharma, Inc.

0.1032
-0.0048-4.44%
盘后：0.10600.0028+2.71%19:59 EDT
成交量：33.87万
成交额：3.56万
市值：163.67万
市盈率：-0.01
高：0.1095
开：0.1090
低：0.1022
收：0.1080
52周最高：11.00
52周最低：0.1022
股本：1,585.93万
流通股本：673.39万
量比：0.18
换手率：5.03%
股息：- -
股息率：- -
每股收益(TTM):-13.5424
每股收益(LYR):-14.8490
净资产收益率：-1811.69%
总资产收益率：-535.73%
市净率：0.16
市盈率(LYR):-0.01

数据加载中...

总览公司新闻资讯公告
2020/10/14

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/08/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/13

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/22

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/17

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/02

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/26

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/06/26

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/13

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/04/03

重要事件披露

8-K - Current report
2020/02/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/02/11

SEC问询函

CORRESP [Cover] - Correspondence
2020/01/24

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/01/17

重要事件披露

8-K - Current report
2019/12/12

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
更多